<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31068952</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The Role of Myeloid-Derived Cells in the Progression of Liver Disease.</ArticleTitle>
        <Pagination>
          <StartPage>893</StartPage>
          <MedlinePgn>893</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">893</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2019.00893</ELocationID>
        <Abstract>
          <AbstractText>Control of homeostasis and rapid response to tissue damage in the liver is orchestrated by crosstalk between resident and infiltrating inflammatory cells. A crucial role for myeloid cells during hepatic injury and repair has emerged where resident Kupffer cells, circulating monocytes, macrophages, dendritic cells and neutrophils control local tissue inflammation and regenerative function to maintain tissue architecture. Studies in humans and rodents have revealed a heterogeneous population of myeloid cells that respond to the local environment by either promoting regeneration or driving the inflammatory processes that can lead to hepatitis, fibrogenesis, and the development of cirrhosis and malignancy. Such plasticity of myeloid cell responses presents unique challenges for therapeutic intervention strategies and a greater understanding of the underlying mechanisms is needed. Here we review the role of myeloid cells in the establishment and progression of liver disease and highlight key pathways that have become the focus for current and future therapeutic strategies.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Weston</LastName>
            <ForeName>Chris John</ForeName>
            <Initials>CJ</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Birmingham, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zimmermann</LastName>
            <ForeName>Henning Wolfgang</ForeName>
            <Initials>HW</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Department III, University Hospital of Aachen, Aachen, Germany.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Adams</LastName>
            <ForeName>David H</ForeName>
            <Initials>DH</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, Medical School, University of Birmingham, Birmingham, United Kingdom.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MR/M009157/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G0300101</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G0300102</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G0700301</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G0802577</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>MC_PC_14123</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>G0400496</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004198" MajorTopicYN="Y">Disease Susceptibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007728" MajorTopicYN="N">Kupffer Cells</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008103" MajorTopicYN="N">Liver Cirrhosis</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008107" MajorTopicYN="N">Liver Diseases</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022423" MajorTopicYN="N">Myeloid Cells</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">circulating monocytes</Keyword>
        <Keyword MajorTopicYN="Y">cirrhosis</Keyword>
        <Keyword MajorTopicYN="Y">fibrosis</Keyword>
        <Keyword MajorTopicYN="Y">hepatitis (general)</Keyword>
        <Keyword MajorTopicYN="Y">hepatocellular carcinoma</Keyword>
        <Keyword MajorTopicYN="Y">macrophage</Keyword>
        <Keyword MajorTopicYN="Y">myeloid derived suppressor cell (MDSC)</Keyword>
        <Keyword MajorTopicYN="Y">neutrophil (PMN)</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>4</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31068952</ArticleId>
        <ArticleId IdType="pmc">PMC6491757</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2019.00893</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Jung S. Macrophages and monocytes in 2017: Macrophages and monocytes: of tortoises and hares. Nat Rev Immunol. (2018) 18:85–6. 10.1038/nri.2017.158</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.158</ArticleId>
            <ArticleId IdType="pubmed">29292392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott CL, T'Jonck W, Martens L, Todorov H, Sichien D, Soen B, et al. . The transcription factor ZEB2 is required to maintain the tissue-specific identities of macrophages. Immunity. (2018) 49:312–25. 10.1016/j.immuni.2018.07.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2018.07.004</ArticleId>
            <ArticleId IdType="pmc">PMC6104815</ArticleId>
            <ArticleId IdType="pubmed">30076102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, et al. . Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell. (2014) 159:1312–26. 10.1016/j.cell.2014.11.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2014.11.018</ArticleId>
            <ArticleId IdType="pmc">PMC4437213</ArticleId>
            <ArticleId IdType="pubmed">25480296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. . Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity. (2014) 40:274–88. 10.1016/j.immuni.2014.01.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2014.01.006</ArticleId>
            <ArticleId IdType="pmc">PMC3991396</ArticleId>
            <ArticleId IdType="pubmed">24530056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. (2017) 17:306–21. 10.1038/nri.2017.11</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.11</ArticleId>
            <ArticleId IdType="pubmed">28317925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. (2014) 60:1090–6. 10.1016/j.jhep.2013.12.025</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2013.12.025</ArticleId>
            <ArticleId IdType="pubmed">24412603</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, et al. . Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. (2012) 18:572–9. 10.1038/nm.2667</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2667</ArticleId>
            <ArticleId IdType="pmc">PMC3364717</ArticleId>
            <ArticleId IdType="pubmed">22388089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. . Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature. (2015) 518:547–51. 10.1038/nature13989</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature13989</ArticleId>
            <ArticleId IdType="pmc">PMC5997177</ArticleId>
            <ArticleId IdType="pubmed">25470051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoeffel G, Chen J, Lavin Y, Low D, Almeida FF, See P, et al. . C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity. (2015) 42:665–78. 10.1016/j.immuni.2015.03.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2015.03.011</ArticleId>
            <ArticleId IdType="pmc">PMC4545768</ArticleId>
            <ArticleId IdType="pubmed">25902481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sheng J, Ruedl C, Karjalainen K. Fetal HSCs versus EMP2s. Immunity. (2015) 43:1025. 10.1016/j.immuni.2015.11.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2015.11.023</ArticleId>
            <ArticleId IdType="pubmed">26682974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mass E, Ballesteros I, Farlik M, Halbritter F, Gunther P, Crozet L, et al. . Specification of tissue-resident macrophages during organogenesis. Science. (2016) 353:aaf4238. 10.1126/science.aaf4238</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aaf4238</ArticleId>
            <ArticleId IdType="pmc">PMC5066309</ArticleId>
            <ArticleId IdType="pubmed">27492475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scott CL, Zheng F, De Baetselier P, Martens L, Saeys Y, De Prijck S, et al. . Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells. Nat Commun. (2016) 7:10321. 10.1038/ncomms10321</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms10321</ArticleId>
            <ArticleId IdType="pmc">PMC4737801</ArticleId>
            <ArticleId IdType="pubmed">26813785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beattie L, Sawtell A, Mann J, Frame TCM, Teal B, de Labastida Rivera F, et al. . Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions. J Hepatol. (2016) 65:758–68. 10.1016/j.jhep.2016.05.037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2016.05.037</ArticleId>
            <ArticleId IdType="pmc">PMC5028381</ArticleId>
            <ArticleId IdType="pubmed">27262757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dal-Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong CH, Petri B, et al. . A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury. J Exp Med. (2015) 212:447–56. 10.1084/jem.20141539</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20141539</ArticleId>
            <ArticleId IdType="pmc">PMC4387291</ArticleId>
            <ArticleId IdType="pubmed">25800956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. (2014) 41:21–35. 10.1016/j.immuni.2014.06.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2014.06.013</ArticleId>
            <ArticleId IdType="pmc">PMC4470379</ArticleId>
            <ArticleId IdType="pubmed">25035951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, Binder CJ, et al. . Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. Gastroenterology. (2010) 138:2477–86, 2486.e1–3. 10.1053/j.gastro.2010.02.051</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2010.02.051</ArticleId>
            <ArticleId IdType="pmc">PMC3114629</ArticleId>
            <ArticleId IdType="pubmed">20206177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Cordone S, et al. . Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms. Arterioscler Thromb Vasc Biol. (2009) 29:831–6. 10.1161/ATVBAHA.109.186791</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.109.186791</ArticleId>
            <ArticleId IdType="pubmed">19359660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zannetti C, Roblot G, Charrier E, Ainouze M, Tout I, Briat F, et al. . Characterization of the inflammasome in human kupffer cells in response to synthetic agonists and pathogens. J Immunol. (2016) 197:356–67. 10.4049/jimmunol.1502301</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1502301</ArticleId>
            <ArticleId IdType="pubmed">27226092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology. (2012) 143:1158–72. 10.1053/j.gastro.2012.09.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2012.09.008</ArticleId>
            <ArticleId IdType="pubmed">22982943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Toki Y, Takenouchi T, Harada H, Tanuma S, Kitani H, Kojima S, et al. . Extracellular ATP induces P2X7 receptor activation in mouse Kupffer cells, leading to release of IL-1beta, HMGB1, and PGE2, decreased MHC class I expression and necrotic cell death. Biochem Biophys Res Commun. (2015) 458:771–6. 10.1016/j.bbrc.2015.02.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2015.02.011</ArticleId>
            <ArticleId IdType="pubmed">25681768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, et al. . Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science. (2010) 330:362–6. 10.1126/science.1195491</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1195491</ArticleId>
            <ArticleId IdType="pubmed">20947763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amaral SS, Oliveira AG, Marques PE, Quintao JL, Pires DA, Resende RR, et al. . Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity. Cell Commun Signal. (2013) 11:10. 10.1186/1478-811X-11-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1478-811X-11-10</ArticleId>
            <ArticleId IdType="pmc">PMC3608937</ArticleId>
            <ArticleId IdType="pubmed">23384127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. . Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. (2012) 482:179–85. 10.1038/nature10809</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10809</ArticleId>
            <ArticleId IdType="pmc">PMC3276682</ArticleId>
            <ArticleId IdType="pubmed">22297845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wree A, McGeough MD, Inzaugarat ME, Eguchi A, Schuster S, Johnson CD, et al. 
NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice. Hepatology. (2018) 67:736–49. 10.1002/hep.29523</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29523</ArticleId>
            <ArticleId IdType="pmc">PMC5849484</ArticleId>
            <ArticleId IdType="pubmed">28902427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knolle PA, Uhrig A, Protzer U, Trippler M, Duchmann R, Meyer zum Buschenfelde KH, et al. . Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology. (1998) 27:93–9. 10.1002/hep.510270116</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.510270116</ArticleId>
            <ArticleId IdType="pubmed">9425923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knolle P, Schlaak J, Uhrig A, Kempf P, Meyer zum Buschenfelde KH, Gerken G. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J Hepatol. (1995) 22:226–9. 10.1016/0168-8278(95)80433-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0168-8278(95)80433-1</ArticleId>
            <ArticleId IdType="pubmed">7790711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heymann F, Peusquens J, Ludwig-Portugall I, Kohlhepp M, Ergen C, Niemietz P, et al. . Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology. (2015) 62:279–91. 10.1002/hep.27793</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27793</ArticleId>
            <ArticleId IdType="pubmed">25810240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>You Q, Cheng L, Kedl RM, Ju C. Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology. (2008) 48:978–90. 10.1002/hep.22395</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.22395</ArticleId>
            <ArticleId IdType="pmc">PMC2600585</ArticleId>
            <ArticleId IdType="pubmed">18712788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan ML, Wang YD, Tian YF, Lai ZD, Yan LN. Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase. World J Gastroenterol. (2010) 16:636–40. 10.3748/wjg.v16.i5.636</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v16.i5.636</ArticleId>
            <ArticleId IdType="pmc">PMC2816279</ArticleId>
            <ArticleId IdType="pubmed">20128035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Song L, Liu M, Ge R, Zhou Q, Liu W, et al. . A proteomics landscape of circadian clock in mouse liver. Nat Commun. (2018) 9:1553. 10.1038/s41467-018-03898-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-018-03898-2</ArticleId>
            <ArticleId IdType="pmc">PMC5908788</ArticleId>
            <ArticleId IdType="pubmed">29674717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ingersoll MA, Spanbroek R, Lottaz C, Gautier EL, Frankenberger M, Hoffmann R, et al. . Comparison of gene expression profiles between human and mouse monocyte subsets. Blood. (2010) 115:e10–9. 10.1182/blood-2009-07-235028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2009-07-235028</ArticleId>
            <ArticleId IdType="pmc">PMC2810986</ArticleId>
            <ArticleId IdType="pubmed">19965649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. (2006) 211:609–18. 10.1016/j.imbio.2006.05.025</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.imbio.2006.05.025</ArticleId>
            <ArticleId IdType="pubmed">16920499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David BA, Rezende RM, Antunes MM, Santos MM, Freitas Lopes MA, Diniz AB, et al. . Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice. Gastroenterology. (2016) 151:1176–91. 10.1053/j.gastro.2016.08.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2016.08.024</ArticleId>
            <ArticleId IdType="pubmed">27569723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al. . Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science. (2007) 317:666–70. 10.1126/science.1142883</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1142883</ArticleId>
            <ArticleId IdType="pubmed">17673663</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover L, Vizcay-Barrena G, et al. . Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell. (2013) 153:362–75. 10.1016/j.cell.2013.03.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2013.03.010</ArticleId>
            <ArticleId IdType="pmc">PMC3898614</ArticleId>
            <ArticleId IdType="pubmed">23582326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization. Ann Rev Immunol. (2015) 33:643–75. 10.1146/annurev-immunol-032414-112220</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-immunol-032414-112220</ArticleId>
            <ArticleId IdType="pubmed">25861979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poschke I, Kiessling R. On the armament and appearances of human myeloid-derived suppressor cells. Clin Immunol. (2012) 144:250–68. 10.1016/j.clim.2012.06.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clim.2012.06.003</ArticleId>
            <ArticleId IdType="pubmed">22858650</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hammerich L, Tacke F. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis. World J Gastrointest Pathophysiol. (2015) 6:43–50. 10.4291/wjgp.v6.i3.43</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4291/wjgp.v6.i3.43</ArticleId>
            <ArticleId IdType="pmc">PMC4540705</ArticleId>
            <ArticleId IdType="pubmed">26301117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shetty S, Lalor PF, Adams DH. Liver sinusoidal endothelial cells—gatekeepers of hepatic immunity. Nat Rev Gastroenterol Hepatol. (2018) 15:555–67. 10.1038/s41575-018-0020-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41575-018-0020-y</ArticleId>
            <ArticleId IdType="pmc">PMC7096836</ArticleId>
            <ArticleId IdType="pubmed">29844586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol. (2012) 302:G1310–21. 10.1152/ajpgi.00365.2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00365.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3378163</ArticleId>
            <ArticleId IdType="pubmed">22442158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, et al. . Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. Clin Sci. (2012) 123:459–71. 10.1042/CS20110515</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/CS20110515</ArticleId>
            <ArticleId IdType="pmc">PMC3369401</ArticleId>
            <ArticleId IdType="pubmed">22545719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heymann F, Hammerich L, Storch D, Bartneck M, Huss S, Russeler V, et al. . Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice. Hepatology. (2012) 55:898–909. 10.1002/hep.24764</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.24764</ArticleId>
            <ArticleId IdType="pmc">PMC4533854</ArticleId>
            <ArticleId IdType="pubmed">22031018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomita K, Freeman BL, Bronk SF, LeBrasseur NK, White TA, Hirsova P, et al. 
CXCL10-mediates macrophage, but not other innate immune cells-associated inflammation in murine nonalcoholic steatohepatitis. Sci Rep. (2016) 6:28786
10.1038/srep28786</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep28786</ArticleId>
            <ArticleId IdType="pmc">PMC4923862</ArticleId>
            <ArticleId IdType="pubmed">27349927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Han J, Man K, Li X, Du J, Chu ES, et al. . CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. J Hepatol. (2016) 64:160–70. 10.1016/j.jhep.2015.09.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2015.09.005</ArticleId>
            <ArticleId IdType="pubmed">26394162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aspinall AI, Curbishley SM, Lalor PF, Weston CJ, Blahova M, Liaskou E, et al. . CX(3)CR1 and vascular adhesion protein-1-dependent recruitment of CD16(+) monocytes across human liver sinusoidal endothelium. Hepatology. (2010) 51:2030–9. 10.1002/hep.23591</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.23591</ArticleId>
            <ArticleId IdType="pmc">PMC2919204</ArticleId>
            <ArticleId IdType="pubmed">20512991</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liaskou E, Zimmermann HW, Li KK, Oo YH, Suresh S, Stamataki Z, et al. . Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology. (2013) 57:385–98. 10.1002/hep.26016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26016</ArticleId>
            <ArticleId IdType="pmc">PMC4194426</ArticleId>
            <ArticleId IdType="pubmed">22911542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zimmermann HW, Seidler S, Nattermann J, Gassler N, Hellerbrand C, Zernecke A, et al. . Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS ONE. (2010) 5:e11049. 10.1371/journal.pone.0011049</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0011049</ArticleId>
            <ArticleId IdType="pmc">PMC2883575</ArticleId>
            <ArticleId IdType="pubmed">20548789</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zimmermann HW, Bruns T, Weston CJ, Curbishley SM, Liaskou E, Li KK, et al. . Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver. Hepatology. (2016) 63:233–46. 10.1002/hep.28285</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.28285</ArticleId>
            <ArticleId IdType="pmc">PMC6016741</ArticleId>
            <ArticleId IdType="pubmed">26473398</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antoniades CG, Quaglia A, Taams LS, Mitry RR, Hussain M, Abeles R, et al. . Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology. (2012) 56:735–46. 10.1002/hep.25657</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.25657</ArticleId>
            <ArticleId IdType="pubmed">22334567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hochst B, Schildberg FA, Sauerborn P, Gabel YA, Gevensleben H, Goltz D, et al. . Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol. (2013) 59:528–35. 10.1016/j.jhep.2013.04.033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2013.04.033</ArticleId>
            <ArticleId IdType="pubmed">23665041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Resheq YJ, Li KK, Ward ST, Wilhelm A, Garg A, Curbishley SM, et al. . Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism of myeloid-derived suppressor cell induction operating in human hepatic stellate cells. J Immunol. (2015) 194:2578–86. 10.4049/jimmunol.1401046</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1401046</ArticleId>
            <ArticleId IdType="pubmed">25667417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. . Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA. (2012) 109:E3186–95. 10.1073/pnas.1119964109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1119964109</ArticleId>
            <ArticleId IdType="pmc">PMC3503234</ArticleId>
            <ArticleId IdType="pubmed">23100531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Kubes P. A reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair. Cell. (2016) 165:668–78. 10.1016/j.cell.2016.03.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.03.009</ArticleId>
            <ArticleId IdType="pubmed">27062926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: a curable disease by 2024?
J Hepatol. (2015) 62(1 Suppl.):S112–20. 10.1016/j.jhep.2014.12.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.12.016</ArticleId>
            <ArticleId IdType="pubmed">25920080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernal W, Wendon J. Acute liver failure. N Engl J Med. (2013) 369:2525–34. 10.1056/NEJMra1208937</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1208937</ArticleId>
            <ArticleId IdType="pubmed">24369077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, et al. . Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology. (2009) 50:261–74. 10.1002/hep.22950</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.22950</ArticleId>
            <ArticleId IdType="pubmed">19554540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hitchcock JR, Cook CN, Bobat S, Ross EA, Flores-Langarica A, Lowe KL, et al. . Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. J Clin Invest. (2015) 125:4429–46. 10.1172/JCI79070</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI79070</ArticleId>
            <ArticleId IdType="pmc">PMC4665792</ArticleId>
            <ArticleId IdType="pubmed">26571395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. (2007) 45:475–85. 10.1002/hep.21498</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.21498</ArticleId>
            <ArticleId IdType="pubmed">17256743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant. (2011) 11:1563–9. 10.1111/j.1600-6143.2011.03579.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-6143.2011.03579.x</ArticleId>
            <ArticleId IdType="pmc">PMC3658307</ArticleId>
            <ArticleId IdType="pubmed">21668640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Movita D, van de Garde MD, Biesta P, Kreefft K, Haagmans B, Zuniga E, et al. . Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct. J Virol. (2015) 89:4809–17. 10.1128/JVI.03733-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.03733-14</ArticleId>
            <ArticleId IdType="pmc">PMC4403491</ArticleId>
            <ArticleId IdType="pubmed">25673700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heymann F, Tacke F. Immunology in the liver–from homeostasis to disease. Nat Rev Gastroenterol Hepatol. (2016) 13:88–110. 10.1038/nrgastro.2015.200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrgastro.2015.200</ArticleId>
            <ArticleId IdType="pubmed">26758786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol. (2008) 84:1410–21. 10.1189/jlb.0308173</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0308173</ArticleId>
            <ArticleId IdType="pmc">PMC2614594</ArticleId>
            <ArticleId IdType="pubmed">18713872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zigmond E, Samia-Grinberg S, Pasmanik-Chor M, Brazowski E, Shibolet O, Halpern Z, et al. . Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol. (2014) 193:344–53. 10.4049/jimmunol.1400574</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1400574</ArticleId>
            <ArticleId IdType="pubmed">24890723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology. (1999) 30:186–95. 10.1002/hep.510300104</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.510300104</ArticleId>
            <ArticleId IdType="pubmed">10385655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laskin DL, Gardner CR, Price VF, Jollow DJ. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology. (1995) 21:1045–50. 10.1002/hep.1840210424</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.1840210424</ArticleId>
            <ArticleId IdType="pubmed">7705777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mossanen JC, Krenkel O, Ergen C, Govaere O, Liepelt A, Puengel T, et al. . Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury. Hepatology. (2016) 64:1667–82. 10.1002/hep.28682</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.28682</ArticleId>
            <ArticleId IdType="pubmed">27302828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, et al. . Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology. (2002) 35:289–98. 10.1053/jhep.2002.30956</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/jhep.2002.30956</ArticleId>
            <ArticleId IdType="pubmed">11826401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yee SB, Bourdi M, Masson MJ, Pohl LR. Hepatoprotective role of endogenous interleukin-13 in a murine model of acetaminophen-induced liver disease. Chem Res Toxicol. (2007) 20:734–44. 10.1021/tx600349f</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/tx600349f</ArticleId>
            <ArticleId IdType="pubmed">17439248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourdi M, Eiras DP, Holt MP, Webster MR, Reilly TP, Welch KD, et al. . Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury. Chem Res Toxicol. (2007) 20:208–16. 10.1021/tx060228l</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/tx060228l</ArticleId>
            <ArticleId IdType="pubmed">17305405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stutchfield BM, Antoine DJ, Mackinnon AC, Gow DJ, Bain CC, Hawley CA, et al. . CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure. Gastroenterology. (2015) 149:1896–909.e14. 10.1053/j.gastro.2015.08.053</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2015.08.053</ArticleId>
            <ArticleId IdType="pmc">PMC4672154</ArticleId>
            <ArticleId IdType="pubmed">26344055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, et al. . Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure. Hepatology. (2014) 59:1564–76. 10.1002/hep.26933</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26933</ArticleId>
            <ArticleId IdType="pubmed">24282114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Triantafyllou E, Pop OT, Possamai LA, Wilhelm A, Liaskou E, Singanayagam A, et al. . MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut. (2018) 67:333–47. 10.1136/gutjnl-2016-313615</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2016-313615</ArticleId>
            <ArticleId IdType="pmc">PMC5868289</ArticleId>
            <ArticleId IdType="pubmed">28450389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krenkel O, Mossanen JC, Tacke F. Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr. (2014) 3:331–43. 10.3978/j.issn.2304-3881.2014.11.01</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3978/j.issn.2304-3881.2014.11.01</ArticleId>
            <ArticleId IdType="pmc">PMC4273118</ArticleId>
            <ArticleId IdType="pubmed">25568858</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campana L, Starkey Lewis PJ, Pellicoro A, Aucott RL, Man J, O'Duibhir E, et al. . The STAT3-IL-10-IL-6 pathway is a novel regulator of macrophage efferocytosis and phenotypic conversion in sterile liver injury. J Immunol. (2018) 200:1169–87. 10.4049/jimmunol.1701247</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1701247</ArticleId>
            <ArticleId IdType="pmc">PMC5784823</ArticleId>
            <ArticleId IdType="pubmed">29263216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ju C, Reilly TP, Bourdi M, Radonovich MF, Brady JN, George JW, et al. . Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem Res Toxicol. (2002) 15:1504–13. 10.1021/tx0255976</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/tx0255976</ArticleId>
            <ArticleId IdType="pubmed">12482232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bernsmeier C, Pop OT, Singanayagam A, Triantafyllou E, Patel VC, Weston CJ, et al. . Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology. (2015) 148:603–15.e14. 10.1053/j.gastro.2014.11.045</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2014.11.045</ArticleId>
            <ArticleId IdType="pubmed">25479139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khakoo SI, Soni PN, Savage K, Brown D, Dhillon AP, Poulter LW, et al. . Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity. Am J Pathol. (1997) 150:963–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1857904</ArticleId>
            <ArticleId IdType="pubmed">9060834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGuinness PH, Painter D, Davies S, McCaughan GW. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut. (2000) 46:260–9. 10.1136/gut.46.2.260</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.46.2.260</ArticleId>
            <ArticleId IdType="pmc">PMC1727823</ArticleId>
            <ArticleId IdType="pubmed">10644323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrivastava S, Mukherjee A, Ray R, Ray RB. Hepatitis C virus induces interleukin-1beta (IL-1beta)/IL-18 in circulatory and resident liver macrophages. J Virol. (2013) 87:12284–90. 10.1128/JVI.01962-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JVI.01962-13</ArticleId>
            <ArticleId IdType="pmc">PMC3807883</ArticleId>
            <ArticleId IdType="pubmed">24006444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hosomura N, Kono H, Tsuchiya M, Ishii K, Ogiku M, Matsuda M, et al. . HCV-related proteins activate Kupffer cells isolated from human liver tissues. Digest Dis Sci. (2011) 56:1057–64. 10.1007/s10620-010-1395-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-010-1395-y</ArticleId>
            <ArticleId IdType="pubmed">20848204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boltjes A, Movita D, Boonstra A, Woltman AM. The role of Kupffer cells in hepatitis B and hepatitis C virus infections. J Hepatol. (2014) 61:660–71. 10.1016/j.jhep.2014.04.026</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.04.026</ArticleId>
            <ArticleId IdType="pubmed">24798624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, et al. . Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol. (2008) 48:914–22. 10.1016/j.jhep.2008.01.028</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2008.01.028</ArticleId>
            <ArticleId IdType="pubmed">18362039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boltjes A, van Montfoort N, Biesta PJ, Op den Brouw ML, Kwekkeboom J, van der Laan LJ, et al. . Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. (2015) 211:1268–78. 10.1093/infdis/jiu599</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiu599</ArticleId>
            <ArticleId IdType="pubmed">25362194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins. J Leukoc Biol. (2007) 82:479–87. 10.1189/jlb.0207128</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0207128</ArticleId>
            <ArticleId IdType="pubmed">17595379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, Abdullah Z, et al. . Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol. (2013) 14:574–83. 10.1038/ni.2573</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.2573</ArticleId>
            <ArticleId IdType="pubmed">23584070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J, Yu Q, Wu W, Huang X, Broering R, Werner M, et al. . TLR2 stimulation strengthens intrahepatic myeloid-derived cell-mediated T cell tolerance through inducing Kupffer cell expansion and IL-10 production. J Immunol. (2018) 200:2341–51. 10.4049/jimmunol.1700540</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1700540</ArticleId>
            <ArticleId IdType="pubmed">29459406</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S, Chen Z, Hu C, Qian F, Cheng Y, Wu M, et al. . Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation. J Immunol. (2013) 190:5142–51. 10.4049/jimmunol.1201625</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1201625</ArticleId>
            <ArticleId IdType="pubmed">23585678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Sun R, Xu L, Yin W, Chen Y, Zheng X, et al. . Kupffer cells support hepatitis B virus-mediated CD8+ T cell exhaustion via hepatitis B core antigen-TLR2 interactions in mice. J Immunol. (2015) 195:3100–9. 10.4049/jimmunol.1500839</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1500839</ArticleId>
            <ArticleId IdType="pubmed">26304988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y, et al. . Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE. (2012) 7:e47648. 10.1371/journal.pone.0047648</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0047648</ArticleId>
            <ArticleId IdType="pmc">PMC3480425</ArticleId>
            <ArticleId IdType="pubmed">23112829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tian Y, Kuo CF, Akbari O, Ou JH. Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission. Immunity. (2016) 44:1204–14. 10.1016/j.immuni.2016.04.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2016.04.008</ArticleId>
            <ArticleId IdType="pmc">PMC4871724</ArticleId>
            <ArticleId IdType="pubmed">27156385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang M, Broering R, Trippler M, Poggenpohl L, Fiedler M, Gerken G, et al. . Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen. J Viral Hepatitis. (2014) 21:860–72. 10.1111/jvh.12216</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jvh.12216</ArticleId>
            <ArticleId IdType="pubmed">24498958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. (2014) 14:181–94. 10.1038/nri3623</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3623</ArticleId>
            <ArticleId IdType="pubmed">24566915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ndugga N, Lightbourne TG, Javaherian K, Cabezas J, Verma N, Barritt ASt, et al. . Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA. BMJ Open. (2017) 7:e013620. 10.1136/bmjopen-2016-013620</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2016-013620</ArticleId>
            <ArticleId IdType="pmc">PMC5372160</ArticleId>
            <ArticleId IdType="pubmed">28336739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. (2018) 15:349–64. 10.1038/s41575-018-0009-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41575-018-0009-6</ArticleId>
            <ArticleId IdType="pubmed">29740166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park JW, Jeong G, Kim SJ, Kim MK, Park SM. Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients. J Gastroenterol Hepatol. (2007) 22:491–7. 10.1111/j.1440-1746.2006.04758.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1746.2006.04758.x</ArticleId>
            <ArticleId IdType="pubmed">17376039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta. (2009) 1792:1062–72. 10.1016/j.bbadis.2009.08.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2009.08.007</ArticleId>
            <ArticleId IdType="pmc">PMC2763970</ArticleId>
            <ArticleId IdType="pubmed">19699298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang W, Metlakunta A, Dedousis N, Zhang P, Sipula I, Dube JJ, et al. . Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes. (2010) 59:347–57. 10.2337/db09-0016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db09-0016</ArticleId>
            <ArticleId IdType="pmc">PMC2809951</ArticleId>
            <ArticleId IdType="pubmed">19934001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, et al. . Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology. (2016) 150:956–67. 10.1053/j.gastro.2015.12.037</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2015.12.037</ArticleId>
            <ArticleId IdType="pmc">PMC4808464</ArticleId>
            <ArticleId IdType="pubmed">26764184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robert O, Boujedidi H, Bigorgne A, Ferrere G, Voican CS, Vettorazzi S, et al. . Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice. J Hepatol. (2016) 64:916–24. 10.1016/j.jhep.2015.11.023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2015.11.023</ArticleId>
            <ArticleId IdType="pubmed">26639395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morinaga H, Mayoral R, Heinrichsdorff J, Osborn O, Franck N, Hah N, et al. . Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice. Diabetes. (2015) 64:1120–30. 10.2337/db14-1238</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-1238</ArticleId>
            <ArticleId IdType="pmc">PMC4375077</ArticleId>
            <ArticleId IdType="pubmed">25315009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyachi Y, Tsuchiya K, Komiya C, Shiba K, Shimazu N, Yamaguchi S, et al. . Roles for cell-cell adhesion and contact in obesity-induced hepatic myeloid cell accumulation and glucose intolerance. Cell Rep. (2017) 18:2766–79. 10.1016/j.celrep.2017.02.039</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.02.039</ArticleId>
            <ArticleId IdType="pubmed">28297678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, et al. . Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut. (2012) 61:416–26. 10.1136/gutjnl-2011-300304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2011-300304</ArticleId>
            <ArticleId IdType="pubmed">21813474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weston CJ, Shepherd EL, Claridge LC, Rantakari P, Curbishley SM, Tomlinson JW, et al. . Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. J Clin Invest. (2015) 125:501–20. 10.1172/JCI73722</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI73722</ArticleId>
            <ArticleId IdType="pmc">PMC4319424</ArticleId>
            <ArticleId IdType="pubmed">25562318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. (2007) 47:571–9. 10.1016/j.jhep.2007.04.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2007.04.019</ArticleId>
            <ArticleId IdType="pmc">PMC2094119</ArticleId>
            <ArticleId IdType="pubmed">17644211</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, et al. . Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest. (2016) 126:859–64. 10.1172/JCI83885</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI83885</ArticleId>
            <ArticleId IdType="pmc">PMC4767345</ArticleId>
            <ArticleId IdType="pubmed">26808498</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mridha AR, Haczeyni F, Yeh MM, Haigh WG, Ioannou GN, Barn V, et al. . TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. Clin Sci. (2017) 131:2145–59. 10.1042/CS20160838</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/CS20160838</ArticleId>
            <ArticleId IdType="pubmed">28687713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balmer ML, Slack E, de Gottardi A, Lawson MA, Hapfelmeier S, Miele L, et al. . The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota. Sci Transl Med. (2014) 6:237ra66. 10.1126/scitranslmed.3008618</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.3008618</ArticleId>
            <ArticleId IdType="pubmed">24848256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan J, Benkdane M, Teixeira-Clerc F, Bonnafous S, Louvet A, Lafdil F, et al. . M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology. (2014) 59:130–42. 10.1002/hep.26607</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26607</ArticleId>
            <ArticleId IdType="pubmed">23832548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han YH, Kim HJ, Na H, Nam MW, Kim JY, Kim JS, et al. . RORalpha induces KLF4-mediated M2 polarization in the liver macrophages that protect against nonalcoholic steatohepatitis. Cell Rep. (2017) 20:124–35. 10.1016/j.celrep.2017.06.017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2017.06.017</ArticleId>
            <ArticleId IdType="pubmed">28683306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du X, Wu Z, Xu Y, Liu Y, Liu W, Wang T, et al. . Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cell Mol Immunol. (2018). 10.1038/s41423-018-0032-0. [Epub ahead of print].</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41423-018-0032-0.</ArticleId>
            <ArticleId IdType="pmc">PMC6828758</ArticleId>
            <ArticleId IdType="pubmed">29735977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. . IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. (2012) 122:3476–89. 10.1172/JCI60777</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI60777</ArticleId>
            <ArticleId IdType="pmc">PMC3461900</ArticleId>
            <ArticleId IdType="pubmed">22945633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Enomoto N, Ikejima K, Bradford BU, Rivera CA, Kono H, Goto M, et al. . Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol. (2000) 15(Suppl):D20–5. 10.1046/j.1440-1746.2000.02179.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1440-1746.2000.02179.x</ArticleId>
            <ArticleId IdType="pubmed">10759216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koop DR, Klopfenstein B, Iimuro Y, Thurman RG. Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intragastric alcohol despite the induction of CYP2E1. Mol Pharmacol. (1997) 51:944–50. 10.1124/mol.51.6.944</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/mol.51.6.944</ArticleId>
            <ArticleId IdType="pubmed">9187260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M, Frasch SC, Li G, Feng D, Gao B, Xu L, et al. 
Role of gp91(phox) in hepatic macrophage programming and alcoholic liver disease. Hepatol Commun. (2017) 1:765–79. 10.1002/hep4.1078</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep4.1078</ArticleId>
            <ArticleId IdType="pmc">PMC5678917</ArticleId>
            <ArticleId IdType="pubmed">29404493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ju C, Mandrekar P. Macrophages and alcohol-related liver inflammation. Alcohol Res. (2015) 37:251–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4590621</ArticleId>
            <ArticleId IdType="pubmed">26717583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Afford SC, Fisher NC, Neil DA, Fear J, Brun P, Hubscher SG, et al. . Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis. J Pathol. (1998) 186:82–9. 10.1002/(SICI)1096-9896(199809)186:1&lt;82::AID-PATH151&gt;3.0.CO;2-D</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-9896(199809)186:1&lt;82::AID-PATH151&gt;3.0.CO;2-D</ArticleId>
            <ArticleId IdType="pubmed">9875144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luna-Casado L, Diez-Ruiz A, Gutierrez-Gea F, Santos-Perez JL, Rico-Irles J, Wachter H, et al. . Increased peripheral mononuclear cells expression of adhesion molecules in alcoholic cirrhosis: its relation to immune activation. J Hepatol. (1997) 27:477–83. 10.1016/S0168-8278(97)80351-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0168-8278(97)80351-0</ArticleId>
            <ArticleId IdType="pubmed">9314124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fisher NC, Neil DA, Williams A, Adams DH. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut. (1999) 45:416–20. 10.1136/gut.45.3.416</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.45.3.416</ArticleId>
            <ArticleId IdType="pmc">PMC1727646</ArticleId>
            <ArticleId IdType="pubmed">10446112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis. (1999) 19:205–19. 10.1055/s-2007-1007110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-1007110</ArticleId>
            <ArticleId IdType="pubmed">10422201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gobejishvili L, Barve S, Joshi-Barve S, Uriarte S, Song Z, McClain C. Chronic ethanol-mediated decrease in cAMP primes macrophages to enhanced LPS-inducible NF-kappaB activity and TNF expression: relevance to alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. (2006) 291:G681–8. 10.1152/ajpgi.00098.2006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00098.2006</ArticleId>
            <ArticleId IdType="pubmed">16751174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, Kolls JK. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res. (2001) 25:444–9. 10.1111/j.1530-0277.2001.tb02233.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1530-0277.2001.tb02233.x</ArticleId>
            <ArticleId IdType="pubmed">11290857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology. (2011) 54:2185–97. 10.1002/hep.24599</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.24599</ArticleId>
            <ArticleId IdType="pmc">PMC3342822</ArticleId>
            <ArticleId IdType="pubmed">21826694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagy LE. The role of innate immunity in alcoholic liver disease. Alcohol Res. (2015) 37:237–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4590620</ArticleId>
            <ArticleId IdType="pubmed">26695748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cameron RG, Blendis LM, Neuman MG. Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem. (2001) 34:195–201. 10.1016/S0009-9120(01)00215-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0009-9120(01)00215-6</ArticleId>
            <ArticleId IdType="pubmed">11408017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guicciardi ME, Trussoni CE, Krishnan A, Bronk SF, Lorenzo Pisarello MJ, O'Hara SP, et al. . Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice. J Hepatol. (2018) 69:676–86. 10.1016/j.jhep.2018.05.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2018.05.018</ArticleId>
            <ArticleId IdType="pmc">PMC6098983</ArticleId>
            <ArticleId IdType="pubmed">29802947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calmus Y, Poupon R. Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases. Clin Res Hepatol Gastroenterol. (2014) 38:550–6. 10.1016/j.clinre.2014.07.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinre.2014.07.007</ArticleId>
            <ArticleId IdType="pubmed">25176586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gong Z, Zhou J, Zhao S, Tian C, Wang P, Xu C, et al. . Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis. Oncotarget. (2016) 7:83951–63. 10.18632/oncotarget.13796</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.13796</ArticleId>
            <ArticleId IdType="pmc">PMC5356637</ArticleId>
            <ArticleId IdType="pubmed">27924062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haselow K, Bode JG, Wammers M, Ehlting C, Keitel V, Kleinebrecht L, et al. . Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages. J Leukoc Biol. (2013) 94:1253–64. 10.1189/jlb.0812396</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1189/jlb.0812396</ArticleId>
            <ArticleId IdType="pubmed">23990628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keitel V, Donner M, Winandy S, Kubitz R, Haussinger D. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun. (2008) 372:78–84. 10.1016/j.bbrc.2008.04.171</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2008.04.171</ArticleId>
            <ArticleId IdType="pubmed">18468513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pean N, Doignon I, Garcin I, Besnard A, Julien B, Liu B, et al. . The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology. (2013) 58:1451–60. 10.1002/hep.26463</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26463</ArticleId>
            <ArticleId IdType="pubmed">23686672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo C, Xie S, Chi Z, Zhang J, Liu Y, Zhang L, et al. 
Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity. (2016) 45:802–16. 10.1016/j.immuni.2016.09.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2016.09.008</ArticleId>
            <ArticleId IdType="pubmed">27692610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biagioli M, Carino A, Cipriani S, Francisci D, Marchiano S, Scarpelli P, et al. . The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of GPBAR1 rescues mice from murine colitis. J Immunol. (2017) 199:718–33. 10.4049/jimmunol.1700183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1700183</ArticleId>
            <ArticleId IdType="pubmed">28607110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hegade VS, Speight RA, Etherington RE, Jones DE. Novel bile acid therapeutics for the treatment of chronic liver diseases. Therap Adv Gastroenterol. (2016) 9:376–91. 10.1177/1756283X16630712</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1756283X16630712</ArticleId>
            <ArticleId IdType="pmc">PMC4830100</ArticleId>
            <ArticleId IdType="pubmed">27134666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. (2006) 6:173–82. 10.1038/nri1785</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri1785</ArticleId>
            <ArticleId IdType="pubmed">16498448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Segal AW. How neutrophils kill microbes. Ann Rev Immunol. (2005) 23:197–223. 10.1146/annurev.immunol.23.021704.115653</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.immunol.23.021704.115653</ArticleId>
            <ArticleId IdType="pmc">PMC2092448</ArticleId>
            <ArticleId IdType="pubmed">15771570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deniset JF, Kubes P.
Neutrophil heterogeneity: bona fide subsets or polarization states?
J Leukoc Biol. (2018) 103:829–38. 10.1002/JLB.3RI0917-361R</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/JLB.3RI0917-361R</ArticleId>
            <ArticleId IdType="pubmed">29462505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubes P.
The enigmatic neutrophil: what we do not know. Cell Tiss Res. (2018) 371:399–406. 10.1007/s00441-018-2790-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00441-018-2790-5</ArticleId>
            <ArticleId IdType="pubmed">29404726</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong J, Johnston B, Lee SS, Bullard DC, Smith CW, Beaudet AL, et al. . A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J Clin Invest. (1997) 99:2782–90. 10.1172/JCI119468</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI119468</ArticleId>
            <ArticleId IdType="pmc">PMC508125</ArticleId>
            <ArticleId IdType="pubmed">9169509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald B, McAvoy EF, Lam F, Gill V, de la Motte C, Savani RC, et al. . Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J Exp Med. (2008) 205:915–27. 10.1084/jem.20071765</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20071765</ArticleId>
            <ArticleId IdType="pmc">PMC2292228</ArticleId>
            <ArticleId IdType="pubmed">18362172</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moles A, Murphy L, Wilson CL, Chakraborty JB, Fox C, Park EJ, et al. . A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J Hepatol. (2014) 60:782–91. 10.1016/j.jhep.2013.12.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2013.12.005</ArticleId>
            <ArticleId IdType="pmc">PMC3960359</ArticleId>
            <ArticleId IdType="pubmed">24333183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McDonald B, Jenne CN, Zhuo L, Kimata K, Kubes P. Kupffer cells and activation of endothelial TLR4 coordinate neutrophil adhesion within liver sinusoids during endotoxemia. Am J Physiol Gastrointest Liver Physiol. (2013) 305:G797–806. 10.1152/ajpgi.00058.2013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpgi.00058.2013</ArticleId>
            <ArticleId IdType="pubmed">24113769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menezes GB, Lee WY, Zhou H, Waterhouse CC, Cara DC, Kubes P. Selective down-regulation of neutrophil Mac-1 in endotoxemic hepatic microcirculation via IL-10. J Immunol. (2009) 183:7557–68. 10.4049/jimmunol.0901786</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0901786</ArticleId>
            <ArticleId IdType="pubmed">19917697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lammermann T, Afonso PV, Angermann BR, Wang JM, Kastenmuller W, Parent CA, et al. . Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature. (2013) 498:371–5. 10.1038/nature12175</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature12175</ArticleId>
            <ArticleId IdType="pmc">PMC3879961</ArticleId>
            <ArticleId IdType="pubmed">23708969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng LG, Qin JS, Roediger B, Wang Y, Jain R, Cavanagh LL, et al. . Visualizing the neutrophil response to sterile tissue injury in mouse dermis reveals a three-phase cascade of events. J Invest Dermatol. (2011) 131:2058–68. 10.1038/jid.2011.179</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/jid.2011.179</ArticleId>
            <ArticleId IdType="pubmed">21697893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. . Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. (2010) 464:104–7. 10.1038/nature08780</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08780</ArticleId>
            <ArticleId IdType="pmc">PMC2843437</ArticleId>
            <ArticleId IdType="pubmed">20203610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Volmering S, Block H, Boras M, Lowell CA, Zarbock A. The neutrophil Btk signalosome regulates integrin activation during sterile inflammation. Immunity. (2016) 44:73–87. 10.1016/j.immuni.2015.11.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2015.11.011</ArticleId>
            <ArticleId IdType="pmc">PMC5030078</ArticleId>
            <ArticleId IdType="pubmed">26777396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, Miller BJ, et al. . PTEN functions to ‘prioritize’ chemotactic cues and prevent ‘distraction’ in migrating neutrophils. Nat Immunol. (2008) 9:743–52. 10.1038/ni.1623</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.1623</ArticleId>
            <ArticleId IdType="pubmed">18536720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foxman EF, Campbell JJ, Butcher EC. Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol. (1997) 139:1349–60. 10.1083/jcb.139.5.1349</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.139.5.1349</ArticleId>
            <ArticleId IdType="pmc">PMC2140208</ArticleId>
            <ArticleId IdType="pubmed">9382879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heit B, Tavener S, Raharjo E, Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J Cell Biol. (2002) 159:91–102. 10.1083/jcb.200202114</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200202114</ArticleId>
            <ArticleId IdType="pmc">PMC2173486</ArticleId>
            <ArticleId IdType="pubmed">12370241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zehrer A, Pick R, Salvermoser M, Boda A, Miller M, Stark K, et al. . A fundamental role of Myh9 for neutrophil migration in innate immunity. J Immunol. (2018) 201:1748–64. 10.4049/jimmunol.1701400</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1701400</ArticleId>
            <ArticleId IdType="pubmed">30068598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, et al. . The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest. (2015) 125:539–50. 10.1172/JCI76887</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI76887</ArticleId>
            <ArticleId IdType="pmc">PMC4319429</ArticleId>
            <ArticleId IdType="pubmed">25562324</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tadie JM, Bae HB, Banerjee S, Zmijewski JW, Abraham E. Differential activation of RAGE by HMGB1 modulates neutrophil-associated NADPH oxidase activity and bacterial killing. Am J Physiol Cell Physiol. (2012) 302:C249–56. 10.1152/ajpcell.00302.2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00302.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3328912</ArticleId>
            <ArticleId IdType="pubmed">22012330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Honda M, Kubes P. Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system. Nat Rev Gastroenterol Hepatol. (2018) 15:206–21. 10.1038/nrgastro.2017.183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrgastro.2017.183</ArticleId>
            <ArticleId IdType="pubmed">29382950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bukong TN, Cho Y, Iracheta-Vellve A, Saha B, Lowe P, Adejumo A, et al. . Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use. J Hepatol. (2018). 69:1145–54. 10.1016/j.jhep.2018.07.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2018.07.005</ArticleId>
            <ArticleId IdType="pmc">PMC6310218</ArticleId>
            <ArticleId IdType="pubmed">30030149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rensen SS, Bieghs V, Xanthoulea S, Arfianti E, Bakker JA, Shiri-Sverdlov R, et al. . Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice. PLoS ONE. (2012) 7:e52411. 10.1371/journal.pone.0052411</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0052411</ArticleId>
            <ArticleId IdType="pmc">PMC3527496</ArticleId>
            <ArticleId IdType="pubmed">23285030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rensen SS, Slaats Y, Nijhuis J, Jans A, Bieghs V, Driessen A, et al. . Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol. (2009) 175:1473–82. 10.2353/ajpath.2009.080999</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.080999</ArticleId>
            <ArticleId IdType="pmc">PMC2751544</ArticleId>
            <ArticleId IdType="pubmed">19729473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zang S, Ma X, Zhuang Z, Liu J, Bian D, Xun Y, et al. . Increased ratio of neutrophil elastase to alpha1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis. Clin Exp Pharmacol Physiol. (2016) 43:13–21. 10.1111/1440-1681.12499</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1440-1681.12499</ArticleId>
            <ArticleId IdType="pubmed">26444279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saijou E, Enomoto Y, Matsuda M, Yuet-Yin Kok C, Akira S, Tanaka M, et al. . Neutrophils alleviate fibrosis in the CCl4-induced mouse chronic liver injury model. Hepatol Commun. (2018) 2:703–17. 10.1002/hep4.1178</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep4.1178</ArticleId>
            <ArticleId IdType="pmc">PMC5983199</ArticleId>
            <ArticleId IdType="pubmed">29881822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ou R, Liu J, Lv M, Wang J, Wang J, Zhu L, et al. . Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice. Endocrine. (2017) 57:72–82. 10.1007/s12020-017-1323-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12020-017-1323-4</ArticleId>
            <ArticleId IdType="pubmed">28508193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Hossain M, Thanabalasuriar A, Gunzer M, Meininger C, Kubes P. Visualizing the function and fate of neutrophils in sterile injury and repair. Science. (2017) 358:111–6. 10.1126/science.aam9690</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aam9690</ArticleId>
            <ArticleId IdType="pubmed">28983053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomson AW, O'Connell PJ, Steptoe RJ, Lu L. Immunobiology of liver dendritic cells. Immunol Cell Biol. (2002) 80:65–73. 10.1046/j.0818-9641.2001.01058.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.0818-9641.2001.01058.x</ArticleId>
            <ArticleId IdType="pubmed">11881616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kudo S, Matsuno K, Ezaki T, Ogawa M. A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocation. J Exp Med. (1997) 185:777–84. 10.1084/jem.185.4.777</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.185.4.777</ArticleId>
            <ArticleId IdType="pmc">PMC2311511</ArticleId>
            <ArticleId IdType="pubmed">9034155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rahman AH, Aloman C. Dendritic cells and liver fibrosis. Biochim Biophys Acta. (2013) 1832:998–1004. 10.1016/j.bbadis.2013.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2013.01.005</ArticleId>
            <ArticleId IdType="pmc">PMC3641166</ArticleId>
            <ArticleId IdType="pubmed">23313573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lukacs-Kornek V, Schuppan D. Dendritic cells in liver injury and fibrosis: shortcomings and promises. J Hepatol. (2013) 59:1124–6. 10.1016/j.jhep.2013.05.033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2013.05.033</ArticleId>
            <ArticleId IdType="pubmed">23727306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goddard S, Youster J, Morgan E, Adams DH. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol. (2004) 164:511–9. 10.1016/S0002-9440(10)63141-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9440(10)63141-0</ArticleId>
            <ArticleId IdType="pmc">PMC1602266</ArticleId>
            <ArticleId IdType="pubmed">14742257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang J, Raper A, Sugita N, Hingorani R, Salio M, Palmowski MJ, et al. . Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. (2006) 107:3600–8. 10.1182/blood-2005-09-3842</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2005-09-3842</ArticleId>
            <ArticleId IdType="pubmed">16397130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai WK, Curbishley SM, Goddard S, Alabraba E, Shaw J, Youster J, et al. . Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function. J Hepatol. (2007) 47:338–47. 10.1016/j.jhep.2007.03.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2007.03.024</ArticleId>
            <ArticleId IdType="pubmed">17467113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collin M, McGovern N, Haniffa M. Human dendritic cell subsets. Immunology. (2013) 140:22–30. 10.1111/imm.12117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imm.12117</ArticleId>
            <ArticleId IdType="pmc">PMC3809702</ArticleId>
            <ArticleId IdType="pubmed">23621371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS, et al. . Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology. (2012) 143:1061–72. 10.1053/j.gastro.2012.06.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2012.06.003</ArticleId>
            <ArticleId IdType="pmc">PMC3459067</ArticleId>
            <ArticleId IdType="pubmed">22705178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strauss O, Dunbar PR, Bartlett A, Phillips A. The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver–a systematic review. J Hepatol. (2015) 62:458–68. 10.1016/j.jhep.2014.10.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.10.006</ArticleId>
            <ArticleId IdType="pubmed">25315649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). Ann Rev Immunol. (2010) 28:445–89. 10.1146/annurev-immunol-030409-101212</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-immunol-030409-101212</ArticleId>
            <ArticleId IdType="pmc">PMC3502616</ArticleId>
            <ArticleId IdType="pubmed">20192806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jurgens B, Hainz U, Fuchs D, Felzmann T, Heitger A. Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood. (2009) 114:3235–43. 10.1182/blood-2008-12-195073</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2008-12-195073</ArticleId>
            <ArticleId IdType="pubmed">19625705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. (2002) 196:459–68. 10.1084/jem.20020121</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20020121</ArticleId>
            <ArticleId IdType="pmc">PMC2196046</ArticleId>
            <ArticleId IdType="pubmed">12186838</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellaneta A, Sumpter TL, Chen L, Tokita D, Thomson AW. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation. J Immunol. (2009) 183:6922–32. 10.4049/jimmunol.0900582</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0900582</ArticleId>
            <ArticleId IdType="pmc">PMC2786082</ArticleId>
            <ArticleId IdType="pubmed">19890047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomson AW, Knolle PA. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol. (2010) 10:753–66. 10.1038/nri2858</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri2858</ArticleId>
            <ArticleId IdType="pubmed">20972472</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Cao X, Zhao J, Zhao H, Wei J, Li Q, et al. . Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells. Clin Exp Immunol. (2017) 188:127–37. 10.1111/cei.12907</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cei.12907</ArticleId>
            <ArticleId IdType="pmc">PMC5343358</ArticleId>
            <ArticleId IdType="pubmed">27891589</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connolly MK, Ayo D, Malhotra A, Hackman M, Bedrosian AS, Ibrahim J, et al. . Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology. (2011) 54:959–68. 10.1002/hep.24429</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.24429</ArticleId>
            <ArticleId IdType="pmc">PMC3166555</ArticleId>
            <ArticleId IdType="pubmed">21574173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henning JR, Graffeo CS, Rehman A, Fallon NC, Zambirinis CP, Ochi A, et al. . Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice. Hepatology. (2013) 58:589–602. 10.1002/hep.26267</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26267</ArticleId>
            <ArticleId IdType="pmc">PMC3638069</ArticleId>
            <ArticleId IdType="pubmed">23322710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heier EC, Meier A, Julich-Haertel H, Djudjaj S, Rau M, Tschernig T, et al. . Murine CD103(+) dendritic cells protect against steatosis progression towards steatohepatitis. J Hepatol. (2017) 66:1241–50. 10.1016/j.jhep.2017.01.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2017.01.008</ArticleId>
            <ArticleId IdType="pubmed">28108233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Velazquez VM, Hon H, Ibegbu C, Knechtle SJ, Kirk AD, Grakoui A. Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology. (2012) 56:2071–81. 10.1002/hep.25904</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.25904</ArticleId>
            <ArticleId IdType="pmc">PMC3747821</ArticleId>
            <ArticleId IdType="pubmed">22711645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, Reith W, et al. . Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci USA. (2012) 109:3012–7. 10.1073/pnas.1117359109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1117359109</ArticleId>
            <ArticleId IdType="pmc">PMC3286988</ArticleId>
            <ArticleId IdType="pubmed">22315415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J, Suh WI, Shin EC. T-cell dysfunction and inhibitory receptors in hepatitis C virus infection. Immune Netw. (2010) 10:120–5. 10.4110/in.2010.10.4.120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4110/in.2010.10.4.120</ArticleId>
            <ArticleId IdType="pmc">PMC2939356</ArticleId>
            <ArticleId IdType="pubmed">20844736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. 
Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. (2013) 58:1461–73. 10.1002/hep.26429</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26429</ArticleId>
            <ArticleId IdType="pmc">PMC3848418</ArticleId>
            <ArticleId IdType="pubmed">23553591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connolly MK, Bedrosian AS, Mallen-St Clair J, Mitchell AP, Ibrahim J, Stroud A, et al. . In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest. (2009) 119:3213–25. 10.1172/JCI37581</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI37581</ArticleId>
            <ArticleId IdType="pmc">PMC2769179</ArticleId>
            <ArticleId IdType="pubmed">19855130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiao J, Sastre D, Fiel MI, Lee UE, Ghiassi-Nejad Z, Ginhoux F, et al. . Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression. Hepatology. (2012) 55:244–55. 10.1002/hep.24621</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.24621</ArticleId>
            <ArticleId IdType="pmc">PMC3245345</ArticleId>
            <ArticleId IdType="pubmed">21898476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blois SM, Piccioni F, Freitag N, Tirado-Gonzalez I, Moschansky P, Lloyd R, et al. . Dendritic cells regulate angiogenesis associated with liver fibrogenesis. Angiogenesis. (2014) 17:119–28. 10.1007/s10456-013-9382-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10456-013-9382-5</ArticleId>
            <ArticleId IdType="pubmed">24068342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramachandran P, Iredale JP, Fallowfield JA. Resolution of liver fibrosis: basic mechanisms and clinical relevance. Semin Liver Dis. (2015) 35:119–31. 10.1055/s-0035-1550057</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0035-1550057</ArticleId>
            <ArticleId IdType="pubmed">25974898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, et al. . Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology. (2002) 36:850–60. 10.1053/jhep.2002.35625</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/jhep.2002.35625</ArticleId>
            <ArticleId IdType="pubmed">12297832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. . Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. (1998) 102:538–49. 10.1172/JCI1018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI1018</ArticleId>
            <ArticleId IdType="pmc">PMC508915</ArticleId>
            <ArticleId IdType="pubmed">9691091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, et al. . Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut. (2001) 48:548–57. 10.1136/gut.48.4.548</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.48.4.548</ArticleId>
            <ArticleId IdType="pmc">PMC1728234</ArticleId>
            <ArticleId IdType="pubmed">11247901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ellis EL, Mann DA. Clinical evidence for the regression of liver fibrosis. J Hepatol. (2012) 56:1171–80. 10.1016/j.jhep.2011.09.024</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2011.09.024</ArticleId>
            <ArticleId IdType="pubmed">22245903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. . Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. (2013) 381:468–75. 10.1016/S0140-6736(12)61425-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(12)61425-1</ArticleId>
            <ArticleId IdType="pubmed">23234725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartneck M, Fech V, Ehling J, Govaere O, Warzecha KT, Hittatiya K, et al. . Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease. Hepatology. (2016) 63:1310–24. 10.1002/hep.28418</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.28418</ArticleId>
            <ArticleId IdType="pubmed">26699087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Preisser L, Miot C, Le Guillou-Guillemette H, Beaumont E, Foucher ED, Garo E, et al. . IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology. (2014) 60:1879–90. 10.1002/hep.27328</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27328</ArticleId>
            <ArticleId IdType="pubmed">25066464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol. (2014) 60:197–209. 10.1016/j.jhep.2013.07.044</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2013.07.044</ArticleId>
            <ArticleId IdType="pubmed">23993913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract. (2010) 2010:8. 10.1155/2010/192543</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2010/192543</ArticleId>
            <ArticleId IdType="pmc">PMC2913673</ArticleId>
            <ArticleId IdType="pubmed">20706677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. . TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. (2007) 13:1324–32. 10.1038/nm1663</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1663</ArticleId>
            <ArticleId IdType="pubmed">17952090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, Horuzsko DD, Arbab AS, Dzutsev A, et al. . The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest. (2018) 128:4870–83. 10.1172/JCI98156</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI98156</ArticleId>
            <ArticleId IdType="pmc">PMC6205377</ArticleId>
            <ArticleId IdType="pubmed">30137027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tornai D, Furi I, Shen ZT, Sigalov AB, Coban S, Szabo G. Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic liver disease in mice. Hepatol Commun. (2019) 3:99–115. 10.1002/hep4.1269</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep4.1269</ArticleId>
            <ArticleId IdType="pmc">PMC6312652</ArticleId>
            <ArticleId IdType="pubmed">30619998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, et al. . CCR2 promotes hepatic fibrosis in mice. Hepatology. (2009) 50:185–97. 10.1002/hep.22952</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.22952</ArticleId>
            <ArticleId IdType="pmc">PMC2705470</ArticleId>
            <ArticleId IdType="pubmed">19441102</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, et al. . CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest. (2009) 119:1858–70. 10.1172/JCI37444</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI37444</ArticleId>
            <ArticleId IdType="pmc">PMC2701864</ArticleId>
            <ArticleId IdType="pubmed">19603542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berres ML, Koenen RR, Rueland A, Zaldivar MM, Heinrichs D, Sahin H, et al. . Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest. (2010) 120:4129–40. 10.1172/JCI41732</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI41732</ArticleId>
            <ArticleId IdType="pmc">PMC2964968</ArticleId>
            <ArticleId IdType="pubmed">20978355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sasaki R, Devhare PB, Steele R, Ray R, Ray RB. Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells. Hepatology. (2017) 66:746–57. 10.1002/hep.29170</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29170</ArticleId>
            <ArticleId IdType="pmc">PMC5570659</ArticleId>
            <ArticleId IdType="pubmed">28318046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heinrichs D, Berres ML, Nellen A, Fischer P, Scholten D, Trautwein C, et al. . The chemokine CCL3 promotes experimental liver fibrosis in mice. PLoS ONE. (2013) 8:e66106. 10.1371/journal.pone.0066106</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0066106</ArticleId>
            <ArticleId IdType="pmc">PMC3684603</ArticleId>
            <ArticleId IdType="pubmed">23799074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rantakari P, Patten DA, Valtonen J, Karikoski M, Gerke H, Dawes H, et al. . Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury. Proc Natl Acad Sci USA. (2016) 113:9298–303. 10.1073/pnas.1604780113</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1604780113</ArticleId>
            <ArticleId IdType="pmc">PMC4995933</ArticleId>
            <ArticleId IdType="pubmed">27474165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology. (2005) 128:138–46. 10.1053/j.gastro.2004.10.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2004.10.005</ArticleId>
            <ArticleId IdType="pubmed">15633130</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mitchell C, Couton D, Couty JP, Anson M, Crain AM, Bizet V, et al. . Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol. (2009) 174:1766–75. 10.2353/ajpath.2009.080632</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2009.080632</ArticleId>
            <ArticleId IdType="pmc">PMC2671265</ArticleId>
            <ArticleId IdType="pubmed">19359521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krenkel O, Puengel T, Govaere O, Abdallah AT, Mossanen JC, Kohlhepp M, et al. . Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology. (2018) 67:1270–83. 10.1002/hep.29544</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29544</ArticleId>
            <ArticleId IdType="pubmed">28940700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefebvre E, Moyle G, Reshef R, Richman LP, Thompson M, Hong F, et al. . Antifibrotic effects of the dual CCR2/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis. PLoS ONE. (2016) 11:e0158156. 10.1371/journal.pone.0158156</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0158156</ArticleId>
            <ArticleId IdType="pmc">PMC4922569</ArticleId>
            <ArticleId IdType="pubmed">27347680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kruger AJ, Fuchs BC, Masia R, Holmes JA, Salloum S, Sojoodi M, et al. . Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet-induced mouse model of nonalcoholic steatohepatitis. Hepatol Commun. (2018) 2:529–45. 10.1002/hep4.1160</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep4.1160</ArticleId>
            <ArticleId IdType="pmc">PMC5944590</ArticleId>
            <ArticleId IdType="pubmed">29761169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baeck C, Wei X, Bartneck M, Fech V, Heymann F, Gassler N, et al. . Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C(+) macrophage infiltration in mice. Hepatology. (2014) 59:1060–72. 10.1002/hep.26783</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26783</ArticleId>
            <ArticleId IdType="pubmed">24481979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Friedman SL, Ratziu V, Harrison SA, Abdelmalek MF, Aithal GP, Caballeria J, et al. . A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology. (2018) 67:1754–67. 10.1002/hep.29477</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29477</ArticleId>
            <ArticleId IdType="pmc">PMC5947654</ArticleId>
            <ArticleId IdType="pubmed">28833331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu PS, Nakamoto N, Ebinuma H, Usui S, Saeki K, Matsumoto A, et al. . C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice. Hepatology. (2013) 58:337–50. 10.1002/hep.26351</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26351</ArticleId>
            <ArticleId IdType="pubmed">23460364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. (2005) 115:209–18. 10.1172/JCI24282</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI24282</ArticleId>
            <ArticleId IdType="pmc">PMC546435</ArticleId>
            <ArticleId IdType="pubmed">15690074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, Zheng HW, Chen H, Xing ZZ, You H, Cong M, et al. . Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-beta1 over pro-inflammatory cytokines. Digest Liver Dis. (2012) 44:328–33. 10.1016/j.dld.2011.11.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.dld.2011.11.005</ArticleId>
            <ArticleId IdType="pubmed">22177317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. . Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA. (2006) 103:5060–5. 10.1073/pnas.0511167103</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0511167103</ArticleId>
            <ArticleId IdType="pmc">PMC1458794</ArticleId>
            <ArticleId IdType="pubmed">16549783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. (2010) 30:245–57. 10.1055/s-0030-1255354</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0030-1255354</ArticleId>
            <ArticleId IdType="pmc">PMC2924662</ArticleId>
            <ArticleId IdType="pubmed">20665377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuda M, Tsurusaki S, Miyata N, Saijou E, Okochi H, Miyajima A, et al. . Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice. Hepatology. (2018) 67:296–312. 10.1002/hep.29421</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29421</ArticleId>
            <ArticleId IdType="pubmed">28779552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, et al. . Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest. (2005) 115:56–65. 10.1172/JCI200522675</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI200522675</ArticleId>
            <ArticleId IdType="pmc">PMC539199</ArticleId>
            <ArticleId IdType="pubmed">15630444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, et al. . Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol. (2007) 178:5288–95. 10.4049/jimmunol.178.8.5288</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.178.8.5288</ArticleId>
            <ArticleId IdType="pubmed">17404313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aoyama T, Inokuchi S, Brenner DA, Seki E. CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology. (2010) 52:1390–400. 10.1002/hep.23795</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.23795</ArticleId>
            <ArticleId IdType="pmc">PMC2947579</ArticleId>
            <ArticleId IdType="pubmed">20683935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, Luedde T, et al. 
The fractalkine receptor CX(3)CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology. (2010) 52:1769–82. 10.1002/hep.23894</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.23894</ArticleId>
            <ArticleId IdType="pubmed">21038415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, et al. . The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. (2007) 204:3037–47. 10.1084/jem.20070885</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20070885</ArticleId>
            <ArticleId IdType="pmc">PMC2118517</ArticleId>
            <ArticleId IdType="pubmed">18025128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol. (2007) 178:2000–7. 10.4049/jimmunol.178.4.2000</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.178.4.2000</ArticleId>
            <ArticleId IdType="pubmed">17277103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ziegler-Heitbrock L, Hofer TP. Toward a refined definition of monocyte subsets. Front Immunol. (2013) 4:23. 10.3389/fimmu.2013.00023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2013.00023</ArticleId>
            <ArticleId IdType="pmc">PMC3562996</ArticleId>
            <ArticleId IdType="pubmed">23382732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. (2002) 31:339–46. 10.1038/ng0802-339</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng0802-339</ArticleId>
            <ArticleId IdType="pubmed">12149612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. . Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. (2011) 479:547–51. 10.1038/nature10599</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature10599</ArticleId>
            <ArticleId IdType="pubmed">22080947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eggert T, Wolter K, Ji J, Ma C, Yevsa T, Klotz S, et al. . Distinct functions of senescence-associated immune responses in liver tumor surveillance and tumor progression. Cancer Cell. (2016) 30:533–47. 10.1016/j.ccell.2016.09.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccell.2016.09.003</ArticleId>
            <ArticleId IdType="pmc">PMC7789819</ArticleId>
            <ArticleId IdType="pubmed">27728804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding T, Xu J, Wang F, Shi M, Zhang Y, Li SP, et al. . High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol. (2009) 40:381–9. 10.1016/j.humpath.2008.08.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.humpath.2008.08.011</ArticleId>
            <ArticleId IdType="pubmed">18992916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, et al. . High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol. (2008) 26:2707–16. 10.1200/JCO.2007.15.6521</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2007.15.6521</ArticleId>
            <ArticleId IdType="pubmed">18509183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foerster F, Hess M, Gerhold-Ay A, Marquardt JU, Becker D, Galle PR, et al. . The immune contexture of hepatocellular carcinoma predicts clinical outcome. Sci Rep. (2018) 8:5351. 10.1038/s41598-018-21937-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-21937-2</ArticleId>
            <ArticleId IdType="pmc">PMC5876395</ArticleId>
            <ArticleId IdType="pubmed">29599491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. . NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. (2004) 431:461–6. 10.1038/nature02924</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02924</ArticleId>
            <ArticleId IdType="pubmed">15329734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. (2005) 121:977–90. 10.1016/j.cell.2005.04.014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2005.04.014</ArticleId>
            <ArticleId IdType="pubmed">15989949</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, et al. . Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology. (2014) 147:1393–404. 10.1053/j.gastro.2014.08.039</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2014.08.039</ArticleId>
            <ArticleId IdType="pmc">PMC4253315</ArticleId>
            <ArticleId IdType="pubmed">25181692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J, Li J, Salcedo R, Mivechi NF, Trinchieri G, Horuzsko A. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res. (2012) 72:3977–86. 10.1158/0008-5472.CAN-12-0938</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-0938</ArticleId>
            <ArticleId IdType="pmc">PMC3694446</ArticleId>
            <ArticleId IdType="pubmed">22719066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delire B, Henriet P, Lemoine P, Leclercq IA, Starkel P. Chronic liver injury promotes hepatocarcinoma cell seeding and growth, associated with infiltration by macrophages. Cancer Sci. (2018) 109:2141–52. 10.1111/cas.13628</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cas.13628</ArticleId>
            <ArticleId IdType="pmc">PMC6029836</ArticleId>
            <ArticleId IdType="pubmed">29727510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li CX, et al. . Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol. (2015) 62:607–16. 10.1016/j.jhep.2014.10.029</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2014.10.029</ArticleId>
            <ArticleId IdType="pubmed">25450711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takai H, Ashihara M, Ishiguro T, Terashima H, Watanabe T, Kato A, et al. . Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. Cancer Biol Ther. (2009) 8:2329–38. 10.4161/cbt.8.24.9985</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cbt.8.24.9985</ArticleId>
            <ArticleId IdType="pubmed">19838081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y, Ye YC, Chen Y, Zhao JL, Gao CC, Han H, et al. . Crosstalk between hepatic tumor cells and macrophages via Wnt/beta-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Cell Death Dis. (2018) 9:793. 10.1038/s41419-018-0818-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-018-0818-0</ArticleId>
            <ArticleId IdType="pmc">PMC6052107</ArticleId>
            <ArticleId IdType="pubmed">30022048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye Y, Xu Y, Lai Y, He W, Li Y, Wang R, et al. . Long non-coding RNA cox-2 prevents immune evasion and metastasis of hepatocellular carcinoma by altering M1/M2 macrophage polarization. J Cell Biochem. (2018) 119:2951–63. 10.1002/jcb.26509</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.26509</ArticleId>
            <ArticleId IdType="pubmed">29131381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan W, Liu X, Ma H, Zhang H, Song X, Gao L, et al. . Tim-3 fosters HCC development by enhancing TGF-beta-mediated alternative activation of macrophages. Gut. (2015) 64:1593–604. 10.1136/gutjnl-2014-307671</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2014-307671</ArticleId>
            <ArticleId IdType="pubmed">25608525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohr-Udilova N, Klinglmuller F, Schulte-Hermann R, Stift J, Herac M, Salzmann M, et al. . Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Sci Rep. (2018) 8:6220. 10.1038/s41598-018-24437-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-24437-5</ArticleId>
            <ArticleId IdType="pmc">PMC5906687</ArticleId>
            <ArticleId IdType="pubmed">29670256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X, Yao W, Yuan Y, Chen P, Li B, Li J, et al. . Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma. Gut. (2017) 66:157–67. 10.1136/gutjnl-2015-310514</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-310514</ArticleId>
            <ArticleId IdType="pubmed">26452628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, et al. . Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology. (2016) 150:1646–58e17. 10.1053/j.gastro.2016.02.040</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2016.02.040</ArticleId>
            <ArticleId IdType="pubmed">26924089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van der Windt DJ, Sud V, Zhang H, Varley PR, Goswami J, Yazdani HO, et al. . Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. (2018). 68:1347–60. 10.1002/hep.29914</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.29914</ArticleId>
            <ArticleId IdType="pmc">PMC6173613</ArticleId>
            <ArticleId IdType="pubmed">29631332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuang DM, Zhao Q, Peng C, Xu J, Zhang JP, Wu C, et al. . Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J Exp Med. (2009) 206:1327–37. 10.1084/jem.20082173</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20082173</ArticleId>
            <ArticleId IdType="pmc">PMC2715058</ArticleId>
            <ArticleId IdType="pubmed">19451266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lens S, Alvarado-Tapias E, Marino Z, Londono MC, E LL, Martinez J, et al. . Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis. Gastroenterology. (2017) 153:1273–83e1. 10.1053/j.gastro.2017.07.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2017.07.016</ArticleId>
            <ArticleId IdType="pubmed">28734831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. (2017) 66:1300–12. 10.1016/j.jhep.2017.02.026</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2017.02.026</ArticleId>
            <ArticleId IdType="pubmed">28267621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, et al. . Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. (2004) 40:1304–11. 10.1002/hep.20452</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.20452</ArticleId>
            <ArticleId IdType="pubmed">15565662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland S, et al. . Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology. (2011) 53:2003–15. 10.1002/hep.24315</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.24315</ArticleId>
            <ArticleId IdType="pubmed">21433043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suh YG, Kim JK, Byun JS, Yi HS, Lee YS, Eun HS, et al. . CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology. (2012) 56:1902–12. 10.1002/hep.25817</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.25817</ArticleId>
            <ArticleId IdType="pmc">PMC3427419</ArticleId>
            <ArticleId IdType="pubmed">22544759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Souza VCA, Pereira TA, Teixeira VW, Carvalho H, de Castro M, D'Assuncao C G, et al. . Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-beta1, IL-13 and oxidative stress. World J Gastroenterol. (2017) 23:5146–57. 10.3748/wjg.v23.i28.5146</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v23.i28.5146</ArticleId>
            <ArticleId IdType="pmc">PMC5537181</ArticleId>
            <ArticleId IdType="pubmed">28811709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haideri SS, McKinnon AC, Taylor AH, Kirkwood P, Starkey Lewis PJ, O'Duibhir E, et al. 
Injection of embryonic stem cell derived macrophages ameliorates fibrosis in a murine model of liver injury. NPJ Regen Med. (2017) 2:14
10.1038/s41536-017-0017-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41536-017-0017-0</ArticleId>
            <ArticleId IdType="pmc">PMC5677947</ArticleId>
            <ArticleId IdType="pubmed">29302350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang L, Han Z, Tian L, Mai P, Zhang Y, Wang L, et al. . Sphingosine 1-phosphate receptor 2 and 3 mediate bone marrow-derived monocyte/macrophage motility in cholestatic liver injury in mice. Sci. Rep. (2015) 5:13423. 10.1038/srep13423</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep13423</ArticleId>
            <ArticleId IdType="pmc">PMC4555045</ArticleId>
            <ArticleId IdType="pubmed">26324256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King A, Houlihan DD, Kavanagh D, Haldar D, Luu N, Owen A, et al. . Sphingosine-1-phosphate prevents egress of hematopoietic stem cells from liver to reduce fibrosis. Gastroenterology. (2017) 153:233–48e16. 10.1053/j.gastro.2017.03.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2017.03.022</ArticleId>
            <ArticleId IdType="pmc">PMC5511862</ArticleId>
            <ArticleId IdType="pubmed">28363640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newsome PN, Fox R, King AL, Barton D, Than NN, Moore J, et al. . Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. Lancet Gastroenterol Hepatol. (2018) 3:25–36. 10.1016/S2468-1253(17)30326-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2468-1253(17)30326-6</ArticleId>
            <ArticleId IdType="pmc">PMC5738975</ArticleId>
            <ArticleId IdType="pubmed">29127060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas JA, Ramachandran P, Forbes SJ. Studies of macrophage therapy for cirrhosis - From mice to men. J Hepatol. (2018) 68:1090–1. 10.1016/j.jhep.2017.11.043</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2017.11.043</ArticleId>
            <ArticleId IdType="pubmed">29317297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraser AR, Pass C, Burgoyne P, Atkinson A, Bailey L, Laurie A, et al. . Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis. Cytotherapy. (2017) 19:1113–24. 10.1016/j.jcyt.2017.05.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcyt.2017.05.009</ArticleId>
            <ArticleId IdType="pmc">PMC5571439</ArticleId>
            <ArticleId IdType="pubmed">28673774</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
